Brain cell grafts in monkeys jump-start human trial for new Parkinson's treatment
July 29, 2024
July 29, 2024
MADISON, Wisconsin, July 29 -- The University of Wisconsin Madison campus issued the following news:
People with Parkinson's disease are receiving a new treatment in a clinical trial started after University of Wisconsin-Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.
Parkinson's disease damages neurons in the brain that produce dopamine, a brain chemical that transmits signals between nerve . . .
People with Parkinson's disease are receiving a new treatment in a clinical trial started after University of Wisconsin-Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.
Parkinson's disease damages neurons in the brain that produce dopamine, a brain chemical that transmits signals between nerve . . .